Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This study is based on the hypothesis that terazosin, a blocker of alpha-1 receptors, will be
effective in reducing excessive sweating caused by antidepressant treatment, and will have
minimal adverse effects.